INSP - NYSE
Inspire Medical Systems, Inc.
$40.47
-0.27%Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA. It also develops a novel, a closed-loop solution that continuously monitors a patient's breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The company was incorporated in 2007 and is headquartered in Golden Valley, Minnesota.
At a Glance
Live SnapshotInspire Medical Systems, Inc. Management Team
Mr. Richard J. Buchholz
Chief Financial Officer
Compensation
$728,155
Mr. Jason P. Kelly
Chief Operations and Quality Officer
Ms. Melissa J. Mann
Chief People Officer
Mr. John C. Rondoni
Chief Product & Innovation Officer
Compensation
$576,716
Mr. Carlton W. Weatherby
Chief Strategy and Growth Officer
Compensation
$809,589
Mr. Randall A. Ban
EVice President of Patient Access &Therapy Development
Compensation
$754,163
Mr. Andreas Henke
Executive Vice President & MD of Europe
Mr. Timothy P. Herbert
Founder, Chairman, Chief Executive Officer & President
Compensation
$1,545,815
Mr. Ivan Lubogo
SVice President of Strategic Sales
Mr. Bryan K. Phillips J.D.
Senior Vice President, General Counsel, Chief Compliance Officer & Corporate Secretary
Compensation
$737,026
Ms. Ezgi Yagci
Vice President of Investor Relations
Inspire Medical Systems, Inc. Insider Positioning
During the last 12 months, insiders have sold $1.64M worth of INSP shares, with no buying activity reported.
3 Months
0
0.00
4.0K
175.94K
-176K
-$176K
3-6 Months
0
0.00
109
10.90K
-11K
-$11K
6-9 Months
0
0.00
3.2K
421.76K
-422K
-$422K
9-12 Months
0
0.00
11.0K
1.03M
-1.0M
-$1.03M
Top Buyers
No buying activity
Top Sellers
Buchholz Richard
Officer: Chief Financial Officer
$1.03M
Mccormick Shawn
Director
$453K
Rondoni John
Officer: See Remarks
$155K
Curet Myriam
Director
$309
Insider Activity Analysis
Net Insider Sentiment
Strong bearish signal with $1.64M net selling. Heavy insider selling may indicate concerns about valuation or near-term prospects.
Buy/Sell Ratio
Very poor ratio. Heavy selling with minimal buying suggests insiders may be concerned about valuation or outlook.
Recent Trend (3 Months)
Heavy recent selling activity. Recent insider sales notably exceed purchases—may warrant investigation into company developments.
Insider Participation
4 insider sellers vs. 0 buyers. Widespread selling across multiple insiders may signal concerns.
Insider Activity Insight
Multiple red flags: Heavy selling, numerous sellers, and continued recent selling create a concerning pattern. Investigate fundamental drivers and consider whether company guidance or industry conditions have deteriorated.
SEC Filings
INSP - Filing history and reports
| Filing Type | Filing Date | Period Ending | Fiscal Year | Actions |
|---|---|---|---|---|
DEF 14A DEF 14A 2026 N/A | March 20, 2026 | April 30, 2026 | 2026 | |
DEF 14A DEF 14A 2025 N/A | March 18, 2025 | May 01, 2025 | 2025 | |
DEF 14A DEF 14A 2024 N/A | March 19, 2024 | May 02, 2024 | 2024 | |
DEF 14A DEF 14A N/A | March 17, 2023 | March 17, 2023 | ||
DEF 14A DEF 14A 2022 N/A | March 16, 2022 | April 28, 2022 | 2022 | |
DEF 14A DEF 14A 2021 N/A | March 16, 2021 | April 29, 2021 | 2021 | |
DEF 14A DEF 14A 2020 N/A | March 16, 2020 | April 30, 2020 | 2020 | |
DEF 14A DEF 14A 2019 N/A | March 20, 2019 | May 02, 2019 | 2019 |
Research Paths
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.